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Sperm whale myoglobin (Mb) has weak dehaloperoxidase activity and catalyzes
the peroxidative dehalogenation of 2,4,6-trichlorophenol (TCP) to 2,6-dichloro-
quinone. Crystals of Mb and of its more active G65T variant were used to study
the binding of TCP, 4-iodophenol (4-IP) and phenol. The structures of crystals
soaked overnight in a 10 mM solution of phenol revealed that a phenol molecule
binds in the proximal cavity, forming a hydrogen bond to the hydroxyl of Tyr146
and hydrophobic contacts which include interactions with C and C of the
proximal histidine His93. The phenol position corresponds to the strongest
xenon binding site, Xe1. It appears that the ligand enters the proximal cavity
through a gate formed by the flexible loops 79–86 and 93–103. TCP and 4-IP do
not bind to Mb in this manner under similar conditions; however, it appears
to be likely that dimethyl sulfoxide (DMSO), which was used at a concentration
of 0.8M to facilitate 4-IP dissolution, binds in the phenol/Xe1 binding site. In
this structure, a water molecule coordinated to the heme iron was replaced by an
oxygen molecule, reflecting the reduction of the heme. Crystals of Mb and G65T
Mb soaked for 5–10 min did not show bound phenol. Kinetic studies of TCP
dechlorination showed that phenol has a dual effect: it acts as a competitive
inhibitor that is likely to interfere with TCP binding at the heme edge and as a
weak activator, likely through binding in the proximal cavity. The lack of phenol
bound at the heme edge in the crystal structures suggests that its inhibitory
binding only takes place when the heme is activated by hydrogen peroxide.
1. Introduction
Myoglobin (Mb) is one of the most thoroughly studied proteins. Its
principal function is as an oxygen carrier, but it has recently been
found that in some organisms it has acquired an additional function
as a dehaloperoxidase, utilizing its heme as the catalytic center to
generate active oxygen species. The first dual-function myoglobin/
dehaloperoxidase (DHP) was discovered in Amphitrite ornata, a
member of the Terebellidae (sea worm) family. This enzyme catalyzes
the oxidative-dehalogenation reaction of polyhalogenated phenols,
utilizing H2O2 (Chen et al., 1996). Ferric myoglobins from species
such as sperm whale or horse have low-level peroxidase activity, but
their physiological role appears to be solely as an oxygen-binding
protein (Osborne et al., 2007). Dual-function globin/peroxidase
proteins in the ferric state bind peroxide in the distal cavity and their
catalytic mechanism is similar to that well established for classical
peroxidases (Osborne et al., 2009).
Peroxidases typically do not have a well defined binding site for
organic substrates; rather, their oxidation takes place at the heme
edge (Poulos, 2010). Surprisingly, crystal binding studies revealed that
DHP binds 4-iodophenol (4-IP), an organic substrate, in the distal
cavity (LaCount et al., 2000). Binding of 4-IP in this mode requires
the distal histidine to swing out of the cavity, which consequently
leads to disassembly of the catalytic machinery. This observation
generated controversy: is the 4-IP binding part of the catalytic cycle
or is it simply opportunistic? Recent results indicate that the latter
is true (Thompson et al., 2010). Other small ligands such as O2, CN
,
CO and imidazole, which bind in the distal cavity, tend to coordinate
to the heme iron. Phenylhydrazine reacts with myoglobin and
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produces a covalent bond between one of the C atoms of the phenyl
group and the heme iron (Ringe et al., 1984).
Ligand binding in the unaltered proximal cavity was limited to the
observation that the exposure of Mb crystals to xenon gas at 709 kPa
resulted in the presence of one Xe atom in the cavity; its position is
referred to as the ‘Xe1 site’ (PDB entry 1j52; W. Radding, E. C. Liong
& G. N. Phillips Jr, unpublished work). Interestingly, the xenon
binding sites in hemoglobin are different from those in myoglobin
and no Xe binding was observed in the hemoglobin proximal cavities,
likely owing to different protein dynamics (Savino et al., 2009). In
general, it was thought that the presence of the proximal histidine in
the cavity prevents the binding of larger molecules. In order to study
the effects of the replacement of the proximal histidine by other
ligands, the ‘cavity mutant’ H93G was engineered (Barrick, 1994).
This mutant was able to accommodate ligands such as 4-methyl-
imidazole (Barrick, 1994), -mercaptoethanol, acetate (Qin et al.,
2006) and phenol (Roach et al., 2000).
Mb ligands such as O2 or CO bind to the heme iron, producing the
A state; the binding is stabilized by electrostatic interactions with
His64 (Lamb et al., 2002; Olson et al., 2007). This binding can be
disrupted upon photon absorption (Gibson & Ainsworth, 1957).
After photodissociation, the ligand migrates into other internal
cavities of the protein and may then diffuse back to the heme iron or
escape into solution (Gibson, 1989; Lim et al., 1993; Scott et al., 2001).
After photodissociation, the CO molecule moves to the primary
docking site, yielding the B state; from there, the CO molecule
migrates into internal cavities named after their xenon binding ability.
Subsequently, the ligands may rebind to the heme iron or leave
through the His64 gate (Schotte et al., 2004; Belogortseva et al., 2007).
Our studies of other Mb variants that mimic DHP and have
increased dehaloperoxidase activity (Du et al., 2011) led us to
investigate whether crystals of one such mutant, G65T, would bind
4-IP, as was observed for DHP. Since 4-IP is poorly soluble in water,
we complemented this study by soaking the crystals in solutions
containing 10 mM phenol. Unexpectedly, the crystal structure of
G65T revealed a phenol molecule bound in the proximal cavity. A
follow-up experiment with wild-type Mb showed the formation of
virtually the same complex, indicating that this mode of phenol
binding is not a result of the mutation but is a property of Mb.
Soaking G65T crystals in 4-IP solution and DMSO yielded an entirely
different complex: an oxyferrous protein with a DMSO molecule
bound in the Xe1/phenol site.
2. Materials and methods
2.1. Site-directed mutagenesis
The pUC19 plasmid with the wild-type sperm whale Mb gene was
a gift from Professor Yoshihito Watanabe (Nagoya University). The
mutagenic primers were designed to be complementary to the sense
strand of sperm whale Mb cDNA. Primers were synthesized and
purified by Integrated DNA Technology (IDT; Coralville, Iowa,
USA). Site-directed mutagenesis was performed using the Quik-
Change method and the results were confirmed by LiCor DNA-
sequence analysis (USC Engencore DNA server, Columbia, South
Carolina, USA) of the entire Mb gene.
2.2. Protein expression and purification
Plasmids containing either the Mb gene or the G65T variant gene
were transformed into the Escherichia coli BL21 (DE3) cell line and
screened successively on LB plates containing 100 mg ml1 ampicillin.
Colonies were picked up from the ampicillin plates, grown overnight
in 5 ml LB containing 100 mg ml1 ampicillin and used to make cell
stocks for protein expression and purification. The recombinant
protein was purified as described previously (Springer & Sligar, 1985)
with modifications. E. coli BL21 (DE3) cells harboring pUC19 were
grown at 310 K in 2YT medium (5 g NaCl, 10 g yeast extract and
16 g tryptone per litre) in the presence of ampicillin (100 mg l1). The
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Table 1
Crystallographic data-collection and refinement statistics.
Complex Wild-type Mb–phenol G65T–phenol G65T–DMSO
PDB code 3u3e 4h07 4h0b
X-ray source SER-CAT 22-ID, APS LS-CAT 21-ID-G, APS LS-CAT 21-ID-G, APS
Wavelength (A˚) 1.0000 0.9800 0.9800
No. of frames (high pass/low pass) 128 100/100 200
Oscillation range () 1.0 1.0 0.5
Crystal-to-detector distance (high pass/low pass) (mm) 150 125/250 150
Temperature (K) 100 100 100
Space group P6 P6 P6
Unit-cell parameters
a (A˚) 90.309 90.531 90.499
b (A˚) 90.309 90.531 90.499
c (A˚) 45.204 45.128 45.319
Unit-cell volume (A˚3) 319279 320310 321438
Solvent content (%) 49.8 48.8 49.6
Matthews coefficient (A˚3 Da1) 2.47 2.42 2.46
Mosaicity () 0.30 0.25 0.25
Resolution range (A˚) 50.0–1.21 (1.23–1.21) 50.0–1.14 (1.16–1.14) 50.0–1.26 (1.31–1.26)
Multiplicity 6.8 (2.7) 7.5 (3.7) 5.6 (4.9)
Average I/(I) 13.3 (2.4) 13.4 (2.6) 16.2 (2.9)
Total No. of reflections 434856 573149 320929
No. of unique reflections 64348 76999 57252
Completeness (%) 99.1 (93.7) 99.9 (98.1) 99.9 (99.9)
Total linear Rmerge (%) 6.7 (41.5) 5.2 (36.6) 6.9 (16.4)
R value (REFMAC) (%) 14.4 13.3 12.7
Rfree (REFMAC) (%) 17.1 15.2 15.3
Ramachandran statistics
Residues in most favored regions (%) 92 93.5 98.0
Residues in additional allowed regions (%) 8.0 6.5 2.0
Residues in generously allowed regions (%) 0 0 0
Residues in disallowed regions (%) 0 0 0
dark-brown cells were collected and frozen at 193 K until use. 20 g of
cells was thawed at 277 K for 16 h in 100 ml lysis buffer (50 mM Tris–
HCl pH 8.0, 1.0 mM EDTA, 0.5 mM dithiothreitol with 20 U DNase,
3 U RNase and 2 mg lysozyme per millilitre). The cells were soni-
cated for 30 min on ice and the cell debris was removed by centri-
fugation. The blood-red supernatant was collected and subjected to
ammonium sulfate fractionation. Mb was precipitated from 55–95%
ammonium sulfate. The precipitate was recovered by centrifugation
and resuspended in a minimum volume of 20 mM Tris–HCl pH 8.0,
1 mM EDTA. The solution was applied onto a Bio-Gel P-100 (Bio-
Rad) gel-filtration column (3.0  30 cm). The appropriate fractions
were pooled, concentrated and applied onto a CM52 pre-swollen
microgranular carboxymethyl cellulose (Whatman) cation-exchange
column (5  15 cm) equilibrated in 25 mM potassium phosphate
pH 6.0. The protein was eluted using a linear pH gradient of 25 mM
potassium phosphate buffer pH 6.0–9.0 containing 1 mM EDTA. The
protein purity was assessed by using the ratio of the Soret absorbance
at 409 nm to the protein absorbance (mostly tryptophan) at 280 nm.
Fractions of Mb with an A409/A280 of greater than 3.5 were considered
to be pure and were pooled. To ensure that only the ferric form was
isolated, the Mb proteins were treated with a 1.7-fold molar excess of
potassium ferricyanide on ice (Belyea et al., 2005). Excess ferricya-
nide was removed by allowing the sample to flow through a Bio-Gel
P-6 DGDesalting Gel (Bio-Rad) gel-filtration column by gravity. The
Mb proteins were concentrated to 10 mg ml1 for crystallization.
2.3. Crystallization
Crystals of G65T and wild-type Mb were grown by the vapor-
diffusion method using a hanging-drop setup under conditions similar
to those reported previously (Matsui et al., 1999) with a well volume
of 500 ml and a drop volume of 2.5 ml protein solution and 2.5 ml well
solution. The conditions used for all crystals consisted of 50 mM Tris–
HCl pH 8.5, between 2.6 and 2.8M ammonium sulfate and 1.0 mM
EDTA. For the phenol-binding experiments, crystals of either Mb or
G65T were soaked for approximately 16 h in 10 mM phenol, 50 mM
Tris–HCl pH 7.4, 1.0 mM EDTA, 3.2M ammonium sulfate solution.
For the 4-IP binding experiment, solid 4-IP was dissolved in a DMSO
solution (60% DMSO, 40% Tris–HCl pH 7.4 with 1.0 mM EDTA)
to obtain a 0.1M 4-IP stock solution. The stock solution was then
diluted to give a 10 mM soaking solution (in 50 mM Tris–HCl pH
8.5, 3.2M ammonium sulfate, 1.0 mM EDTA) with a final DMSO
concentration of 0.8M (6%). No precipitation was observed upon
dilution. The crystals were soaked for approximately 16 h. All crystals
were cryo-conditioned by soaking them in 20%(v/v) ethylene glycol-
enriched mother liquor for a few seconds and were flash-cooled in N2
vapor at 95 K.
2.4. X-ray diffraction data collection and structure determination
Data were collected on the SER-CAT 22-ID and LS CAT 21-ID-G
beamlines at the Advanced Photon Source (APS), Argonne National
Laboratory (ANL), Argonne, Illinois, USA. The data were indexed
and processed with the HKL-2000 software package (Otwinowski &
Minor, 1997). Data-collection and processing statistics are listed in
Table 1. The structures were determined using molecular replace-
ment with AMoRe (Navaza, 1994) or Phaser (McCoy et al., 2007)
from the CCP4 suite of programs (Winn et al., 2011), using the G65T
structure (PDB entry 3ock; Du et al., 2011) as the search model.
Structure rebuilding and subsequent refinements were performed
with TURBO-FRODO (Roussel & Cambillau, 1991) and REFMAC5
(Murshudov et al., 2011). Coordinates were superposed using the
LSQKAB program (Kabsch, 1976) from the CCP4 suite. Figs. 1–4 and
Supplementary Figs. 1 and 2 were prepared using TURBO-FRODO.
Fig. 5 was prepared using MolScript (Kraulis, 1991) and Raster3D
(Merritt & Bacon, 1997).
2.5. Dehaloperoxidase assay
The effects of phenol binding on the peroxidase activity of Mb
were measured using a UV absorption spectroscopy-based assay as
described previously (Du et al., 2011). Briefly, assays were conducted
on a Cary 400 spectrophotometer at 277 K and the absorbance peak
at 272 nm was monitored to detect the concentration of the product
2,4-dichloroquinone versus time. Generally, Mb (5 mM) and variable
concentrations of TCP were mixed in 100 mM potassium phosphate
buffer pH 7 in the absence or presence of phenol (0, 250 and 500 mM).
The reactions were then initiated by the addition of 2 mM H2O2. The
time between phenol addition and readout was 3–4 min or, in the case
of the annealing experiment, 3 d. The initial velocity was calculated
using the Cary WinUV software based on the linear initial portion
of each reaction. The initial rates as a function of TCP concentration
were fitted to the Michaelis–Menten equation using the Prism 5
software.
3. Results and discussion
3.1. Crystallographic results
3.1.1. Structures of the Mb–phenol and G65T–phenol complexes.
The structures of the Mb–phenol and G65T–phenol complexes were
very similar; their superposition yielded a r.m.s. deviation between
structural communications
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Figure 1
Stereoview of the heme environment in the Mb–phenol complex. The final 2Fo  Fc OMIT electron density is contoured at the 1.3 level.
the positions of the C atoms of 0.12 A˚. Below, where differences
were observed the data for the G65T–phenol complex are given in
parentheses.
The crystals had excellent scattering power and the electron
density for the complex covered the whole molecule with the
exception of a few side chains. The electron density for the heme and
the proximal cavity of the Mb–phenol complex is shown in Fig. 1 and
that for the G65T–phenol complex is shown in Supplementary Fig.
S11. Unlike in the DHP–4-IP complex (LaCount et al., 2000), the
phenol molecule binds in the proximal cavity. The binding site is not
saturated; the occupancy factors are approximately 0.6 and 0.8 in the
G65T and Mb complexes, respectively. The phenol fits snugly into a
hydrophobic part of the proximal cavity (Fig. 2); its hydroxyl forms
a 2.8 A˚ (2.7 A˚) hydrogen bond to the phenolic hydroxyl of Tyr146,
which in turn forms a 2.7 A˚ hydrogen bond to the carbonyl of Ile99
(Fig. 3). The planes of the phenol molecule and the imidazole ring
of His93 are not parallel; they interact through contacts between the
C1 and O atoms of the phenol molecule and the C and C atoms
of His93 (3.3 and 3.0 A˚, respectively; Supplementary Fig. S2). The
phenol binding site corresponds to the Xe1 binding site, which is the
main binding site for xenon (PDB entry 1j52). A bound CO molecule
was also observed in this site in the structure of the D-state
(photolyzed) Mb–CO complex (PDB entry 1do3; Ostermann et al.,
2000). These complexes are remarkably similar; the r.m.s. deviation
between the positions of the C atoms is 0.15 A˚ (0.19 A˚). In both
complexes a water molecule is bound to the heme iron, as expected
for the ferric state.
To analyze the effects of phenol binding, the structure of aquomet-
Mb (PDB entry 1a6k; Vojtechovsky´ et al., 1999) was selected because
it was determined at a comparable resolution, 1.1 A˚, and the crystals
were also obtained from ammonium sulfate pH 7.0. A superposition
of the structures of the phenol complex and native Mb yielded an
r.m.s. deviation of 0.48 A˚ between the positions of the C atoms.
Comparison of these two structures revealed a change of the Leu89
rotamer, shown in Fig. 3, which resulted in a 1.9 A˚ shift of C. It is
apparent that the side-chain movement arises from phenol binding,
as the same rotamer change is also observed for G65Tand the G65T–
phenol complex. The occupancy of the rotamers of Leu89 correlates
with the phenol occupancy. Additional comparisons show that the
r.m.s. deviation between the positions of the C atoms of the G65T–
phenol complex and native G65T is 0.07 A˚, while the r.m.s. deviation
between the positions of the C atoms of native G65T and aquomet-
Mb is 0.49 A˚. This relatively high r.m.s. deviation is likely to arise
from different packing (the space groups are P6 and P21), and the
most affected region is residues 148–152 of the C-terminus, where the
positions of the C atoms shift by up to 1.9 A˚.
The visible spectrum of the phenol complex is not significantly
different from that of unliganded Mb (not shown). Isothermal titra-
tion calorimetric measurements did not allow us to determine the
binding constant for phenol. No peaks were observed upon titrant
injections, but rather a drift in the baseline. The most likely inter-
pretation is that the binding process is too slow to be measured using
this technique.
3.1.2. G65T–dimethyl sulfoxide complex. In the structure of G65T
crystals soaked in 4-IP solution there was no electron density that
might correspond to a 4-IP molecule. However, there was a density
feature in the distal cavity that corresponded very well to an oxygen
molecule coordinated to the Fe atom. It appears that 4-IP reduced the
heme to the ferrous state; this reaction enabled the binding of oxygen
present in the soaking solution.
In the proximal cavity, there was a strong electron-density peak
(15 in an OMIT Fo  Fo map) at the Xe1/phenol binding site. In the
OMIT 2Fo  Fo map the corresponding peak also appeared to be too
large for a water molecule (Fig. 4); no bound water was observed at
this site in other Mb structures. The hydrophobic environment of the
peak provides the plausible interpretation that a molecule of DMSO
present in the soaking solution bound in this site. The density is not
structural communications
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Figure 2
Proximal cavity in the Mb–phenol complex. The phenol molecule, shown in yellow,
fits snugly within its hydrophobic part.
Figure 3
Superposition of the Mb–phenol complex (shown in atom-type colors) with
aquomet-Mb (PDB entry 1a6k; shown in blue). The presence of the phenol ligand
in the proximal binding site displaces the Leu89 side chain by approximately 1.9 A˚.
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: EN5522).
well structured and it appears that the DMSO molecule, if indeed
present, is rotationally disordered. When a molecule of DMSO was
inserted into the model and refined, the values of the B factors were
15 A˚2 for the S atom and approximately twice that for the terminal
atoms. Those observations indicate that the ligand is heavier than a
water molecule but is disordered. As we had no alternative hypo-
thesis, we refer to this structure as the G65T–DMSO complex.
The G65T–DMSO structure was superposed with that of the
Mb–CO complex in the A state (CO bound to Fe; PDB entry 2mgk;
Quillin et al., 1993). The r.m.s deviation between the positions of the
C atoms was 0.34 A˚. It was also superposed with the D-state struc-
ture of Mb–CO (PDB entry 1do3; Ostermann et al., 2000), which has
a CO molecule bound at the Xe1 site. The r.m.s. deviation between
the positions of the C atoms was 0.18 A˚. The electron density for the
heme and its environment in the G65T–DMSO complex is shown in
Fig. 4.
3.2. Putative gate to the proximal cavity
Based on CO photodissociation studies, it is assumed that small
ligands such as CO and Xe enter the proximal cavity from the distal
cavity through a transient channel between Ile107 and the heme
(Lamb et al., 2002). However, it appears to be unlikely that larger
ligands such as phenol or imidazole can enter the proximal cavity
through the His64 gate and use the same path because the heme
provides a formidable hindrance. H93G Mb, which is often referred
to as ‘the cavity mutant,’ has been extensively used to study the
effects of proximal ligands on the properties of myoglobin. Success
in binding ligands such as 4-methylimidazole, -mercaptoethanol,
phenol and acetate in the proximal cavity in the absence of the
proximal histidine side chain preceded our observation (Barrick,
1994; Qin et al., 2006). Since the observed phenol binding took place
in crystals, loop movement is likely to be responsible for phenol entry
into the cavity rather than major protein unfolding. NMR studies
provide more information about the molecular dynamics. NMR
structures of Mb (PDB entry 1myf; Osapay et al., 1994) revealed four
flexible loops: residues 15–23, 48–59, 79–86 and 93–103. The top
NMR structures together with the Mb–phenol complex are shown in
Fig. 5. The 15–23 and 48–59 loops are too far away from the proximal
cavity to be the phenol entrance site. Thus, the movement of loops
79–86 and 93–103, individually or in a correlated fashion, is likely to
generate an opportunity for entrance of the ligand.
3.3. The effects of phenol binding on the peroxidase activity of Mb
Short (5–10 min) soaking of Mb crystals did not show binding of
phenol, indicating that the process is relatively slow in crystals. Long
soaks of Mb crystals in saturated solutions of the substrate TCP did
not show TCP binding, which is consistent with our modeling studies,
indicating that there is not sufficient room for the binding of TCP
structural communications
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Figure 4
Stereoview of the heme environment in subunit A of the G65T–DMSO complex. The final 2Fo  Fc electron density is contoured at the 1.2 level. The electron feature
assigned to a partially disordered DMSO molecule overlaps with the phenol binding site and also the Xe1 binding site.
Figure 5
The structure of the G65T–phenol complex superposed on the mobile loops
observed in the NMR structures of Mb. The peptide chain in the G65T–phenol
complex is shown in blue; the variable loops are shown in other colors.
in the proximal cavity (not shown). However, our kinetics studies of
peroxidative TCP dechlorination in the presence of phenol showed
that phenol is mainly a competitive inhibitor of this reaction (Fig. 6,
Table 2). If the deviations from Michaelis–Menten kinetics apparent
in Fig. 6 are disregarded, the Ki value is about 0.5 mM. One expla-
nation of these observations is that the peroxidase reaction catalyzed
by Mb takes place at the edge of the heme, as established for classical
peroxidases (Poulos, 2010). The absence of TCP or phenol bound at
the heme edge in crystals soaked in concentrated solutions (about 20
 Ki for phenol) suggests that binding only takes place when Mb
is activated by hydrogen peroxide. We soaked crystals with both
hydrogen peroxide and phenol, but as in previous experiments no
bound ligand was observed, probably owing to the low stability of
the active intermediates. The observed slight increase of Vmax as a
function of phenol concentration (Table 2) may perhaps relate to
phenol binding in the proximal cavity and increased ‘electron push’
or to altered protein dynamics.
The crystal-soaking experiments resulted in partial occupancies of
phenol, suggesting that the rate of diffusion is a significant factor in
crystals. On the other hand, the kinetics experiments showed only
modest differences between dehaloperoxidase activity measurements
when the protein was or was not annealed for 3 d in phenol (Table 2).
We estimate that in the absence of annealing the protein was exposed
to phenol for 2–3 min. Thus, in contrast to the situation in crystals,
where soaks of about 10 min did not show phenol binding, in solution
a time of several minutes appears to be sufficient for entry of phenol
into the proximal cavity.
4. Conclusions
Even in the presence of its Fe-coordinating histidine, the proximal
cavity of Mb has sufficient room to bind modest-sized molecules such
as phenol or DMSO in the Xe1 binding site. Phenol binding some-
what alters the electronic state of the proximal histidine as judged
from the increased Vmax for peroxidative dechlorination of TCP. It
was previously noticed that myoglobin, although a binding protein,
does not have a channel leading to its binding site, but rather depends
on the molecular dynamics to create a path through the distal histi-
dine swinging out of the pocket and creating the ‘gate’. The same is
true at the opposite side of the heme; there is no channel leading to
the proximal cavity. Ligand entry into the cavity is likely to take place
through a ‘side path’, not through the distal cavity.
The affinity for substrate/halophenol binding at the heme edge,
which is necessary for the dehalogenase activity, appears to be small
in the absence of the cosubstrate hydrogen peroxide. The same is true
for phenol functioning as a competitive inhibitor, which is also likely
to bind at the heme edge.
Data were collected on the LS CAT 21-ID-G and SER-CAT 22-ID
beamlines at the Advanced Photon Source, Argonne National
Laboratory. Use of the Advanced Photon Source was supported by
the US Department of Energy, Office of Basic Energy Sciences under
Contract No. W-31-109-Eng-38. Financial support was provided by
the National Science Foundation (MCB 0820456).
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